Elevance Health Inc (ELV)

Receivables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	171,340,000	168,622,000	165,712,000	160,672,000	156,595,000	153,247,000	149,130,000	144,349,000	138,639,000	133,882,000	129,218,000	124,631,000	121,867,000	117,450,000	112,966,000	109,168,000	104,213,000	100,179,000	96,756,000	94,234,000
Receivables	US$ in thousands	-941,000	-692,000	-768,000	-763,000	-744,000	-495,000	-367,000	-698,000	-648,000	-455,000	-323,000	-406,000	-374,000	-160,000	-321,000	-282,000	93,000	91,000	296,000	—
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1,120.57	1,100.87	326.88	—

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $171,340,000K ÷ $-941,000K
= —

Elevance Health Inc's receivables turnover ratio has been relatively stable over the past eight quarters, ranging from 9.53 to 10.70. A higher receivables turnover ratio indicates that the company is able to collect its accounts receivable more efficiently.

In Q3 2022, the ratio peaked at 10.70, suggesting that the company was collecting its receivables at a faster pace during that period. However, in Q1 2023, the ratio decreased to 9.56, indicating a slight slowdown in the collection of accounts receivable.

Overall, Elevance Health Inc's receivables turnover ratios fall within a consistent range, reflecting a generally effective accounts receivable management strategy. It is essential for the company to continue monitoring this ratio to ensure timely collection of receivables and maintain healthy cash flows.